Search - tctmd.com

Displaying 321 - 340 of 764

Sort: Relevancy | Date

News Daily News

ISAR-DESIRE 3: Drug-Coated Balloon Shows Durable Antirestenotic Effect in DES Restenosis

L.A. McKeown

June 03, 2015

News Conference News EuroPCR 2015

Trials Explore the Potential of Biodegradable-Polymer Stents

Caitlin E. Cox

May 21, 2015

News Conference News EuroPCR 2015

MASTER: Biodegradable-Polymer DES Tested Against BMS in STEMI

Caitlin E. Cox

May 20, 2015

News Industry News

New Data Presented At EuroPCR 2015 Demonstrate Strong Performance Of The SYNERGY™ Bioabsorbable Polymer Stent System Over Four Years

May 19, 2015

News Conference News EuroPCR 2015

Evolving DES Technology May Benefit Diabetic Patients

Caitlin E. Cox

May 19, 2015

News Industry News

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

May 19, 2015

News Industry News

Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease

May 19, 2015

News Daily News

Uso Viable de BRS en Lesiones Calcificadas Con Preparación Agresiva

April 29, 2015

News Daily News

BRS Use in Calcified Lesions Feasible With Aggressive Preparation

April 29, 2015

News Daily News

Un Registro Coreano Revela un Mayor Uso de PCI en el Manejo de la Enfermedad de Tronco Coronario Izdo. Con Mejores Resultados

L.A. McKeown

April 03, 2015

News Daily News

Korean Registry Shows PCI Increasingly Used for Left Main Disease, With Improving Outcomes

L.A. McKeown

April 03, 2015

News Conference News ACC 2015

ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted

Todd Neale

March 20, 2015

News Conference News ACC 2015

BEST: Due to Less TVR, CABG Still Favored Over PCI in Patients with Multivessel Disease

L.A. McKeown

March 16, 2015

News Daily News

Los BRF son Equiparables a los SLF en el Tratamiento de Pacientes ‘del Mundo Real’ con Reestenosis Intra-Stent

March 04, 2015

News Daily News

DCB Matches DES in Treating ‘Real-World’ Patients With In-Stent Restenosis

March 04, 2015

Presentation

Comparison of Everolimus- and Biolimus-Eluting Coronary Stents with Everolimus-Eluting BVS

Presenter: A.Puricel

February 26, 2015

News Daily News

EVERBIO II Published: BVS Matches Leading DES for Midterm Outcomes

L.A. McKeown

February 26, 2015

News Daily News

第 3 年 XAMI 率：急性心梗患者置入 EES 和 SES 的极晚期支架血栓事件率同样较低

L.A. McKeown

January 29, 2015

News Daily News

XAMI at 3 Years: Rates of Very Late Stent Thrombosis Similarly Low for EES, SES in Acute MI Patients

L.A. McKeown

January 29, 2015

News Daily News

XAMI a los 3 Años: Similares Índices Bajos de Trombosis Muy Tardía del Stent para SLE, SLS y Pacientes que sufren IAM

L.A. McKeown

January 29, 2015

Advertisement

ISAR-DESIRE 3: Drug-Coated Balloon Shows Durable Antirestenotic Effect in DES Restenosis

Trials Explore the Potential of Biodegradable-Polymer Stents

MASTER: Biodegradable-Polymer DES Tested Against BMS in STEMI

New Data Presented At EuroPCR 2015 Demonstrate Strong Performance Of The SYNERGY™ Bioabsorbable Polymer Stent System Over Four Years

Evolving DES Technology May Benefit Diabetic Patients

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease

Uso Viable de BRS en Lesiones Calcificadas Con Preparación Agresiva

BRS Use in Calcified Lesions Feasible With Aggressive Preparation

Un Registro Coreano Revela un Mayor Uso de PCI en el Manejo de la Enfermedad de Tronco Coronario Izdo. Con Mejores Resultados

Korean Registry Shows PCI Increasingly Used for Left Main Disease, With Improving Outcomes

ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted

BEST: Due to Less TVR, CABG Still Favored Over PCI in Patients with Multivessel Disease

Los BRF son Equiparables a los SLF en el Tratamiento de Pacientes ‘del Mundo Real’ con Reestenosis Intra-Stent

DCB Matches DES in Treating ‘Real-World’ Patients With In-Stent Restenosis

Comparison of Everolimus- and Biolimus-Eluting Coronary Stents with Everolimus-Eluting BVS

EVERBIO II Published: BVS Matches Leading DES for Midterm Outcomes

第 3 年 XAMI 率：急性心梗患者置入 EES 和 SES 的极晚期支架血栓事件率同样较低

XAMI at 3 Years: Rates of Very Late Stent Thrombosis Similarly Low for EES, SES in Acute MI Patients

XAMI a los 3 Años: Similares Índices Bajos de Trombosis Muy Tardía del Stent para SLE, SLS y Pacientes que sufren IAM

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content